Trial Profile
X-HALE: Observation of Xolair therapy under daily clinical practice Physical activity and quality of life in children and adolescents from 6 to <18 years
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2014
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Acronyms X-HALE
- Sponsors Novartis
- 18 Nov 2014 New trial record